G. Zürcher

3.6k total citations · 1 hit paper
42 papers, 3.0k citations indexed

About

G. Zürcher is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, G. Zürcher has authored 42 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Neurology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in G. Zürcher's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). G. Zürcher is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). G. Zürcher collaborates with scholars based in Switzerland, Italy and United States. G. Zürcher's co-authors include M. Da Prada, M. Da Prada, Andrew F. Wilks, Andrew Ziemiecki, Stephen J. Ralph, Ailsa G. Harpur, Karin Jorga, Da Prada M, Jasper Dingemanse and Edilio Borroni and has published in prestigious journals such as Angewandte Chemie International Edition, Molecular and Cellular Biology and Journal of Neurochemistry.

In The Last Decade

G. Zürcher

42 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range

1976 1.0k citations M. Da Prada, G. Zürcher profile →

Peers

Countries citing papers authored by G. Zürcher

Since Specialization

Citations

This map shows the geographic impact of G. Zürcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Zürcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Zürcher more than expected).

Fields of papers citing papers by G. Zürcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Zürcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Zürcher. The network helps show where G. Zürcher may publish in the future.

Co-authorship network of co-authors of G. Zürcher

This figure shows the co-authorship network connecting the top 25 collaborators of G. Zürcher. A scholar is included among the top collaborators of G. Zürcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Zürcher. G. Zürcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bisubstrate Inhibitors of Catechol O‐Methyltransferase (COMT): the Crucial Role of the Ribose Structural Unit for Inhibitor Binding Affinity 2006 ·ChemMedChem ·Ralph Paulini, Christian Trindler, C. Lerner, (unknown), W. Bernd Schweizer, Roland Jakob‐Roetne, G. Zürcher, Edilio Borroni, François Diederich	22
2	Bisubstrate Inhibitors of the Enzyme Catechol O‐Methyltransferase (COMT): Efficient Inhibition Despite the Lack of a Nitro Group 2004 ·ChemBioChem ·Ralph Paulini, C. Lerner, Roland Jakob‐Roetne, G. Zürcher, Edilio Borroni, François Diederich	31
3	Bisubstrate inhibitors for the enzyme catechol-O-methyltransferase (COMT): influence of inhibitor preorganisation and linker length between the two substrate moieties on binding affinity 2002 ·Organic & Biomolecular Chemistry ·C. Lerner, B. Masjost, A. Ruf, Völker Gramlich, Roland Jakob‐Roetne, G. Zürcher, Edilio Borroni, François Diederich	49
4	Investigation of a correlation between monoamine oxidase B and catechol-O-methyltransferase activity in human blood cells 2000 ·European Journal of Pharmaceutical Sciences ·Jasper Dingemanse, G. Zürcher, R. Kettler	3
5	Structure-Based Design, Synthesis, and in vitro Evaluation of Bisubstrate Inhibitors for CatecholO-Methyltransferase (COMT) 2000 ·Chemistry - A European Journal ·B. Masjost, (unknown), Edilio Borroni, G. Zürcher, Fritz K. Winkler, Roland Jakob‐Roetne, François Diederich	56
6	Mosé Da Prada and the discovery of tolcapone. 1998 ·PubMed ·Edilio Borroni, J. Borgulya, G. Zürcher	1
7	Pharmacokinetics and pharmacodynamics after oral and intravenous administration of tolcapone, a novel adjunct to Parkinson's disease therapy 1998 ·European Journal of Clinical Pharmacology ·Karin Jorga, (unknown), P. Heizmann, G. Zürcher	27
8	The Effect of COMT Inhibition by Tolcapone on Tolerability and Pharmacokinetics of Different Levodopa/Benserazide Formulations 1997 ·European Neurology ·Karin Jorga, (unknown), Monique Schmitt, (unknown), G. Zürcher, (unknown)	23
9	Pharmacodynamics of benserazide assessed by its effects on endogenous and exogenous levodopa pharmacokinetics* 1997 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), G. Zürcher, Nolan Wood, (unknown)	22
10	Multiple-dose clinical pharmacology of the catechol- O -methyl-transferase inhibitor tolcapone in elderly subjects 1996 ·European Journal of Clinical Pharmacology ·Jasper Dingemanse, Karin Jorga, G. Zürcher, (unknown), G Sędek, (unknown), P. van Brummelen	59
11	Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-DOPA and dopamine in rats 1995 ·European Journal of Pharmacology ·Alessandro Napolitano, G. Zürcher, M. Da Prada	38
12	Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans* 1995 ·Clinical Pharmacology & Therapeutics ·Jasper Dingemanse, Karin Jorga, Monique Schmitt, Ronald Gieschke, (unknown), G. Zürcher, M. Da Prada, P. van Brummelen	96
13	Expression of Functional Membrane‐Bound and Soluble Catechol‐O‐Methyltransferase in Escherichia coli and a Mammalian Cell Line 1992 ·Journal of Neurochemistry ·P. Malherbe, Barbara Bertocci, Patrick Caspers, G. Zürcher, M. Da Prada	38
14	Tyramine content of preserved and fermented foods or condiments of Far Eastern cuisine 1992 ·Psychopharmacology ·M. Da Prada, G. Zürcher	10
15	Simple automated high-performance liquid chromatographic column-switching technique for the measurement of dopa and 3-O-methyldopa in plasma 1990 ·Journal of Chromatography B Biomedical Sciences and Applications ·G. Zürcher, M. Da Prada	22
16	Ro 40-7592: inhibition of COMT in rat brain and extracerebral tissues 1990 ·PubMed ·G. Zürcher, A. Colzi, M. Da Prada	67
17	Monoclonal antibodies recognizing both soluble and membrane bound catechol-O-methyltransferase 1990 ·PubMed ·Barbara Bertocci, Gianni Garotta, G. Zürcher, V. Miggiano, M. Da Prada	1
18	On tyramine, food, beverages and the reversible MAO inhibitor moclobemide. 1988 ·PubMed ·Da Prada M, G. Zürcher, (unknown), (unknown)	157
19	Bioavailability of L-Dopa after Madopar HBS Administration in Healthy Volunteers 1987 ·European Neurology ·C Crevoisier, (unknown), G. Zürcher, M. Da Prada	42
20	Rapid and Sensitive Single‐Step Radiochemical Assay for Catechol‐O‐Methyltransferase 1982 ·Journal of Neurochemistry ·G. Zürcher, M. Da Prada	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact